Related Experiment Video
Updated: Jun 21, 2026

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells
Published on: October 20, 2023
Progress and Prospects: genetic treatments for disorders of bones and joints
C H Evans1, S C Ghivizzani, P D Robbins
1Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. cevans@bidmc.harvard.edu
Abstract:
Gene therapies directed toward the treatment of arthritis and tissue repair continue to be the most active areas of research for bone and joint diseases. In the past 2 years, two trials in rheumatoid arthritis have been completed. a Phase I study reporting safety and a Phase I/II study that has yet to be published. An additional, small study has reported the first evidence of clinical efficacy. Two Phase I trials of gene therapy for osteoarthritis have also been initiated. There is much preclinical activity in developing AAV vectors for future trials in the gene therapy of arthritis. Research into tissue repair and regeneration remains at the preclinical stage, but a considerable volume of research attests to the promise of gene transfer in this arena, especially in the context of bone healing. For tissue repair, the major research questions are still which genes to use and how best to deliver them.
Insights
Gene therapy shows promise for arthritis and tissue repair, with ongoing clinical trials and preclinical research focusing on gene transfer for bone healing and joint disease treatment.
Area of Science:
- Orthopedics and Regenerative Medicine
- Molecular and Genetic Therapies
Background:
- Arthritis and tissue repair are key research areas for bone and joint diseases.
- Gene therapy is emerging as a significant therapeutic strategy.
Purpose of the Study:
- To review the current state of gene therapy research for arthritis and tissue repair.
- To highlight recent clinical trials and preclinical advancements.
Main Methods:
- Review of completed and ongoing clinical trials (Phase I, I/II) for rheumatoid arthritis and osteoarthritis.
- Assessment of preclinical research, particularly involving adeno-associated virus (AAV) vectors for arthritis and gene transfer for bone healing.
Main Results:
- Two gene therapy trials for rheumatoid arthritis have concluded, one focusing on safety and another on efficacy.
- Early clinical efficacy has been observed in a small study.
- Two Phase I trials for osteoarthritis gene therapy have commenced.
- Significant preclinical work is underway for AAV vectors and gene transfer in tissue repair, especially bone healing.
Conclusions:
- Gene therapy is an active and promising area for treating arthritis and promoting tissue repair.
- Further research is needed to identify optimal genes and delivery methods for tissue repair applications.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Gene Therapy
Gene Therapy
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Growth of Cartilage and Bone Tissue
What is Genetic Engineering?